Filing Flows › CareDx (CDNA) › Q1 2025
CareDx (CDNA) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 30, 2025
CareDx (CDNA) reported revenue of $84.7M for the first quarter 2025 (Q1 2025), +18% from a year earlier and -2% from the quarter before. Operating margin was -15.8%, net loss $10.4M (12.2% of revenue).
CareDx, Q1 2025: revenue $84.7M (+18% year over year), operating margin -15.8%, net loss $10.4M, operating cash flow −$26.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $84.7M | -2% | +18% |
| Operating profit | −$13.4M | — | — |
| Net earnings | −$10.4M | — | — |
| Operating cash flow | −$26.6M | — | — |
What changed
Revenue was $84.7M in Q1 2025, up 18% year over year and down 2% from the previous quarter. Testing services revenue was the largest line at 73% of revenue. Testing services revenue added $8.1M year over year (up 15%), 64% of the total change.
Operating costs exceeded revenue by $13.4M, an operating margin of -15.8%. Total costs grew 4% against revenue growth of 18%. The fastest-growing cost line was Other operating costs (+30%). The quarter ended with a net loss of $10.4M, after a profit of $78.0M the previous quarter. Non-operating items added $3.1M, -30% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$26.6M. Non-cash charges added back $3.6M of depreciation and amortization and $8.9M of share-based compensation. Working capital and other items used $28.8M. Capital expenditures of $1.6M exceeded it, leaving free cash flow of −$28.2M.
Questions
What was CareDx's revenue in the first quarter 2025?
CareDx (CDNA) reported revenue of $84.7M for the first quarter 2025 (Q1 2025), +18% from a year earlier and -2% from the quarter before.
Was CareDx profitable in the first quarter 2025?
Operating loss was $13.4M (-15.8% of revenue) and net loss $10.4M.
Source: CareDx 10-Q on SEC EDGAR.